For the second time in the last four months, pharmaceutical Bristol-Myers Squibb is announcing a major recall of its Avalide blood pressure tablets distributed on the U.S. mainland and Puerto Rico.
On Thursday, the company announced it will be collecting 64 million tablets due to the potential for reduced effectiveness, Reuters reported. The medication was produced at Bristol’s plants in Humacao and Evansville, Indiana.
Bristol-Myers said the action was a “precautionary measure.
In September, the pharmaceutical — which jointly markets the drug with Sanofi-Aventis — recalled 62 lots, or 60 million tablets, of the drug manufactured in Puerto Rico.
Avalide, sold under the brand name Avapro, is one of Bristol-Myers’ blockbuster products, with $1.3 billion in sales in 2009.
Business reporter with 27 years of experience writing for weekly and daily newspapers, as well as trade publications in Puerto Rico. My list of former employers includes Caribbean Business, The San Juan Star, and the Puerto Rico Daily Sun, among others. My areas of expertise include telecommunications, technology, retail, agriculture, tourism, banking and most other areas of the economy.
“As part of our commitment, we’ll be initiating a series of community dialogues with the residents of the island municipalities of Vieques and Culebra, as well as with their mayors and the top municipal executives of Ceiba, Cataño and San Juan.”